{"id":12006,"date":"2023-07-27T14:02:00","date_gmt":"2023-07-27T14:02:00","guid":{"rendered":"https:\/\/pruefer.eu\/?p=12006"},"modified":"2023-08-01T09:10:16","modified_gmt":"2023-08-01T09:10:16","slug":"chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3","status":"publish","type":"post","link":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/","title":{"rendered":"Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3"},"content":{"rendered":"\n\n\n\n\n
\n
\n
\n
\n
\n <\/div>\n

(III) Comparison of Opposition Proceedings at the EPO<\/strong> and Nullity Proceedings at the UPC<\/strong><\/p>\n

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks \u2013 for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.<\/p>\n

The UPC now offers a second chance by providing another forum for central revocation of a European patent throughout the territory of the UPC states. Moreover, revocation actions can be brought before the UPC at any time after grant, independently of opposition proceedings before the EPO. Therefore, it is indeed a (further) effective attack on the European patent, and even in case European opposition and appeal proceedings were already pending in parallel. In the German legal system, on the other hand, there is the restriction \u2013 besides the fact that it only acts against the German part of the European patent \u2013 that revocation proceedings are inadmissible as long as European opposition and appeal proceedings are still pending.<\/p>\n

The opposition procedure at the EPO is essentially a written procedure with an oral hearing at the end; the oral hearing takes place before a three-member panel and may last a full day. The UPC follows a similar approach – a written procedure followed by an oral hearing. However, there is a tight timing in the invalidity proceedings before the UPC. The UPC requires the patent owner to file a response within two months (while the EPO sets a four-month deadline); then the plaintiff may file a reply to the response within two months, and the defendant (patent owner) may file a rejoinder to the reply within one month, limited to the points raised in the reply.<\/p>\n

The faster procedure before the UPC may allow for tactics on the nullity plaintiff\u2019s side that weren’t available before. This is because, whilst the plaintiff can prepare his facts and arguments (and potential counter-arguments) well in advance of lodging the action, pressure is put on the defendant (patent owner) with respect to time and effort. Therefore, an efficient interaction of the patent owner with his team of attorneys is important. If on the other hand the patent owner starts with an infringement action, pressure will rather lie on the side of the infringement defendant in case he seeks to raise a defence by counter-action of nullity; this is because the counter-action should then be lodged soon after the start of the infringement action for being considered during the infringement proceedings.<\/p>\n

A difference is that filing an invalidity action at the UPC is more expensive than filing an opposition at the EPO: court fee amounts to 20 000 EURO, whereas at the EPO it is presently only 880 EURO. The costs at the UPC are comparable to filing a German nullity action \u2013 however with the difference that the decision is effective throughout the UPC territory.<\/p>\n

Although the opposition divisions of the EPO could, in principle, order the parties to pay the costs, this very rarely happens in practice; the predominant rule is that each party bears its own costs. The UPC Rules of Procedure provide that a winning party is entitled to reimbursement of its costs insofar as these are reasonable and proportionate.<\/p>\n

There is also a risk that matters before the UPC will become complicated if the validity of a European patent is challenged by a counterclaim to an infringement action. In opposition proceedings before the EPO, only the validity itself is examined – the EPO does not consider infringement at all.<\/p>\n

However, there is also the possibility that the proceedings before the UPC are split into two \u2013 i.e. a bifurcated system like the one practiced in Germany \u2013 where infringement and the validity are decided separately by two different courts (the former by the Local Division, the latter by the Central Division).<\/p>\n

While all isolated revocation actions are heard by a central chamber of the UPC, revocation counterclaims in response to infringement may instead be brought before the then competent local chamber of the UPC; however, it is at the discretion of the local chamber to refer the revocation counterclaim to the central chamber. Practice will show which principle \u2013 the one-track or the two-track procedure \u2013 will bring overall advantages before the UPC and possibly prevail in the long run.<\/p>\n

As can be seen from this overview, there are similarities but also differences between the opposition procedure before the EPO and the nullity procedure before the UPC. Probably the most significant difference in practice is the relatively strict time regime foreseen for the proceedings before the UPC. This is especially true when the infringement and revocation counterclaims run concurrently and thus require effective and expeditious action by the parties and their representatives. However with the benefit of a decision within a short time.<\/p>\n

Further to Part 1: (I) Introduction and Overview<\/strong><\/a><\/p>\n

Further to Part 2: (II) Strategic Considerations of using the new EU Court, or Opting out<\/strong><\/a><\/p>\n <\/div>\n

\n
\n \n
\n \n \n <\/a>\n <\/div>\n
\n \n \u4f5c\u8005 \n \n
Dr. Andreas Oser<\/div>\n \n Andreas Oser \u81ea 1991 \u5e74\u4ece\u4e8b\u5de5\u4e1a\u77e5\u8bc6\u4ea7\u6743\u9886\u57df\u7684\u5de5\u4f5c\uff0c\u81ea 1995 \u5e74\u8d77\u6210\u4e3a\u5fb7\u56fd\u4e13\u5229\u548c\u5546\u6807\u5c40\u4ee5\u53ca\u6b27\u6d32\u4e13\u5229\u5c40\u8ba4\u53ef\u7684\u4e13\u5229\u5f8b\u5e08\uff0c\u5e76\u4e14\u4ece 2002 \u5e74\u5f00\u59cb\u62c5\u4efb Pr\u00fcfer & Partner \u7684\u7ba1\u7406\u5408\u4f19\u4eba\u3002\u6b64\u5916\uff0c\u4ed6\u8fd8\u53d6\u5f97\u4e86\u6cd5\u5b66\u7855\u58eb\u7684\u5b66\u4f4d\uff08\u56fd\u9645\u5de5\u4e1a\u77e5\u8bc6\u4ea7\u6743\u6cd5\u5b66\u7855\u58eb\uff09\uff08\u54c8\u6839\u5927\u5b66\uff09\u3002\u5728\u8fdb\u5165\u5230\u5de5\u4e1a\u77e5\u8bc6\u4ea7\u6743\u9886\u57df\u5de5\u4f5c\u524d\uff0c\u4ed6\u5c31\u8bfb\u4e8e\u5f17\u83b1\u5821\u5927\u5b66\u7684\u5316\u5b66\u4e13\u4e1a\uff0c\u968f\u540e\u5728\u6155\u5c3c\u9ed1\u9a6c\u514b\u65af\u666e\u6717\u514b\u7814\u7a76\u6240\u653b\u8bfb\u4e86\u535a\u58eb\u5b66\u4f4d\u548c\u535a\u58eb\u540e\u3002 <\/a>\n <\/div>\n \n
\n \u53d1\u5e03\u65e5\u671f
27. 7 \u6708 2023<\/div> \u5206\u7c7b
UPC-Updates<\/div> <\/div>\n <\/div>\n <\/div>\n \n
\n

\u5230\u65b0\u95fb\u9875\u9762<\/a><\/p>\n <\/div>\n <\/div> \n <\/div>\n<\/section>\n\n\n\n

\n
\n\n
\n

\u5176\u4ed6\u5173\u4e8eUPC\u7edf\u4e00\u4e13\u5229\u6cd5\u5ead\u7684\u6587\u7ae0<\/h2>\n
<\/div>\n
\n\t\t\t\t\n \n<\/svg>\n<\/span>\n\t\t\t\tPrevious<\/span>\n\t\t\t<\/a>\n\t\t\t<\/div>\n
\n
\n\t
\n\n\n\n\n

UPC\u5927\u5bb6\u5ead\u7684\u58ee\u5927 \uff01 \u7f57\u9a6c\u5c3c\u4e9a\u6b63\u5f0f\u52a0\u5165UPC<\/h4>\n 2024 \u5e74 9 \u6708 1 \u65e5\uff0c\u7f57\u9a6c\u5c3c\u4e9a\u5c06\u6210\u4e3a\u300a\u7edf\u4e00\u4e13\u5229\u6cd5\u9662\u534f\u5b9a\u300b\u7684\u7b2c 18 \u4e2a\u6210\u5458\u56fd\u3002\u300a\u7edf\u4e00\u4e13\u5229\u6cd5\u9662\u534f\u5b9a\u300b\uff08UPCA\uff09\u7684\u6279\u51c6\u4e66\u5df2\u4e8e2024\u5e745\u670831\u65e5\u7b7e\u7f72\u3002\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

Comment on UPC Court Decision of May 6, 2024<\/h4>\n Before the Paris Local Division, in a case where the defendant had forced an intervener into the proceedings pursuant to Rule 316A RoP (forced intervention), the intervener has obtained a period of one month for filing its Application to Intervene as well as for filing its Statement in Intervention. Contrary to Rule 316.2 RoP, which mentions a “further period” for filing the Statement in Intervention, the Court did not set any such further period.\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

\u4ece UPC \u7684\u89d2\u5ea6\u6765\u770b\u6743\u5229\u8981\u6c42\u7684\u89e3\u91ca\u3001\u9648\u8ff0\u8d23\u4efb\u548c\u4e8b\u5b9e\u8bc1\u660e – UPC_CoA_335\/2023<\/h4>\n UPC \u7684\u9996\u6279\u88c1\u51b3\u5df2\u7ecf\u4e0b\u8fbe\uff0c\u4e86\u89e3 UPC \u5728\u5e7f\u6cdb\u8ba8\u8bba\u7684\u6743\u5229\u8981\u6c42\u89e3\u91ca\u3001\u4e8b\u5b9e\u9648\u8ff0\u548c\u4e3e\u8bc1\u8d23\u4efb\u4ee5\u53ca\u521b\u9020\u6027\u8003\u8651\u7b49\u95ee\u9898\u4e0a\u7684\u7acb\u573a\u5c06\u662f\u4ee4\u4eba\u5174\u594b\u7684\u3002\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

Comparison of opposition proceedings at the EPO and revocation actions at the UPC \u2013 advantages and disadvantages<\/h4>\n Since the introduction of the Unified Patent Court (UPC) in June 2023, a new system for central attacking the validity of and thereby to nullify a European Patent has been introduced. If a European patent of concern is an EU Unitary Patent, or if a classically validated European patent was not opted out from the competence of the UPC, a central revocation action under the UPC now exists in parallel to an opposition before the European Patent Office (EPO). Therefore, the question arises: what are the pros and cons of challenging the validity either before the EPO or before the UPC? The present report provides some guidance and discusses the main advantages and disadvantages of each system \u2013 which eventually is a matter of strategic considerations whether and which advantage may prevail \u2013 be it costs, timing, speed of proceedings, and possibly other issues.\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

Dorothea Hofer \u535a\u58eb\u83b7\u5f97\u6b27\u6d32\u4e13\u5229\u8bc9\u8bbc\u8bc1\u4e66<\/h4>\n \u6211\u4eec\u5f88\u8363\u5e78\u7684\u5411\u60a8\u544a\u77e5\uff0c\u6211\u4eec\u7684\u7ba1\u7406\u5408\u4f19\u4eba\u591aDorothea Hofer \u535a\u58eb\u83b7\u5f97\u4e86\u7531\u9a6c\u65af\u7279\u91cc\u8d6b\u7279\u5927\u5b66\uff08University of Maastricht\uff09\u4e0e\u7279\u91cc\u5c14\u6b27\u6d32\u6cd5\u5b66\u9662\uff08the Academy of European Law \u7f29\u5199ERA\uff09\u5408\u4f5c\u9881\u53d1\u7684\u6b27\u6d32\u4e13\u5229\u8bc9\u8bbc\u8bc1\u4e66\u3002\u8be5\u8bc1\u4e66\u5305\u62ec\u7edf\u4e00\u4e13\u5229\u6cd5\u9662\uff08#UPC).\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3<\/h4>\n Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks \u2013 for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 2<\/h4>\n During a seven-years transition phase, the jurisdiction of the future Unified Patent Court (UPC) can be declared inapplicable, by way of an opt-out request by the IP right holder, to a pending European patent application (“EP application”), to a granted European patent (“EP”), or to a supplementary protection certificate (“SPC”). This possibility was introduced to build confidence by users on the long run. If opted-out, disputes will then continue to be handled by national courts on a country-by-country basis. Once a European patent has been opted out, it is excluded from the jurisdiction of the UPC for its entire life.\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 1<\/h4>\n June 1, 2023 marks the beginning of a new era in European patent law: the new European Unitary Patent system entered into force, consisting of the Unitary Patent (UP) and the Unified Patent Court (UPC). 50 years after the introduction of the European Patent Convention and millions of European patents filed, this may be the most prominent change in European patent practice. The Unitary Patent adds as a third pillar to the classical European patents and the national patents. The Unified Patent Court will have an influence on both the unitary patent and the classical European patents as a modern and efficient litigation system.\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

The Unified Patent Court will start on June 1, 2023<\/h4>\n Years of planning finally become reality: The official starting signal has now been given! Germany ratified the Agreement on a Unified Patent Court (UPC) on February 17, 2023.\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div>
\n\t
\n\n\n\n\n

Start of the Sunrise Period for Filing Opt-out Requests with the Unified Patent Court on March 1, 2023<\/h4>\n According to the current schedule, the Unified Patent Court will start its work on June 1, 2023.\n\nThe so-called sunrise period, during which opt-out requests can be filed with the Unified Patent Court for granted European patents or published European patent applications will start on March 1, 2023, according to the current planning of the Unified Patent Court.\t<\/div>\n\t \u9605\u8bfb\u6587\u7ae0<\/a>\n \t\t\t<\/div>\n<\/div> <\/div>\n
\n \n\t\t\t\t\n \n<\/svg>\n<\/span>\n\t\t\t\tNext<\/span>\n\t\t\t<\/a><\/div>\n \n <\/div>\n <\/div>\n<\/section>","protected":false},"excerpt":{"rendered":"

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks \u2013 for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.<\/p>\n","protected":false},"author":12,"featured_media":11832,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[178],"tags":[],"class_list":["post-12006","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-upc-updates-zh-hans"],"acf":[],"yoast_head":"\nChances and Risks of the New European Unitary Patentand New Unified Patent Court - Part 3 - Pr\u00fcfer & Partner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chances and Risks of the New European Unitary Patentand New Unified Patent Court - Part 3 - Pr\u00fcfer & Partner\" \/>\n<meta property=\"og:description\" content=\"Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks \u2013 for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Pr\u00fcfer & Partner\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-27T14:02:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-01T09:10:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pruefer.eu\/wp-content\/uploads\/2023\/07\/UPC_AO_EN.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1316\" \/>\n\t<meta property=\"og:image:height\" content=\"1244\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Schantl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Schantl\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/\"},\"author\":{\"name\":\"Schantl\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#\\\/schema\\\/person\\\/51bff1b60ea94e55d8aed0696c87f75d\"},\"headline\":\"Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3\",\"datePublished\":\"2023-07-27T14:02:00+00:00\",\"dateModified\":\"2023-08-01T09:10:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/\"},\"wordCount\":15,\"publisher\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/UPC_AO_EN.png\",\"articleSection\":[\"UPC-Updates\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/\",\"name\":\"Chances and Risks of the New European Unitary Patentand New Unified Patent Court - Part 3 - Pr\u00fcfer & Partner\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/UPC_AO_EN.png\",\"datePublished\":\"2023-07-27T14:02:00+00:00\",\"dateModified\":\"2023-08-01T09:10:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/UPC_AO_EN.png\",\"contentUrl\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/UPC_AO_EN.png\",\"width\":1316,\"height\":1244},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/2023\\\/07\\\/27\\\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#website\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/\",\"name\":\"Pr\u00fcfer & Partner\",\"description\":\"Patentanwaltskanzlei f\u00fcr Pharma, Biotech, Life Sciences und Physik \u2013 M\u00fcnchen\",\"publisher\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#organization\",\"name\":\"Pr\u00fcfer & Partner\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/logo.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Pr\u00fcfer & Partner\"},\"image\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/zh-hans\\\/#\\\/schema\\\/person\\\/51bff1b60ea94e55d8aed0696c87f75d\",\"name\":\"Schantl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9b62b3711d001a8ab054887513338b1773069eca4c7d3becec0f7ab592eb411?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9b62b3711d001a8ab054887513338b1773069eca4c7d3becec0f7ab592eb411?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9b62b3711d001a8ab054887513338b1773069eca4c7d3becec0f7ab592eb411?s=96&d=mm&r=g\",\"caption\":\"Schantl\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chances and Risks of the New European Unitary Patentand New Unified Patent Court - Part 3 - Pr\u00fcfer & Partner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/","og_locale":"zh_CN","og_type":"article","og_title":"Chances and Risks of the New European Unitary Patentand New Unified Patent Court - Part 3 - Pr\u00fcfer & Partner","og_description":"Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks \u2013 for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.","og_url":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/","og_site_name":"Pr\u00fcfer & Partner","article_published_time":"2023-07-27T14:02:00+00:00","article_modified_time":"2023-08-01T09:10:16+00:00","og_image":[{"width":1316,"height":1244,"url":"https:\/\/pruefer.eu\/wp-content\/uploads\/2023\/07\/UPC_AO_EN.png","type":"image\/png"}],"author":"Schantl","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Schantl"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/#article","isPartOf":{"@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/"},"author":{"name":"Schantl","@id":"https:\/\/pruefer.eu\/zh-hans\/#\/schema\/person\/51bff1b60ea94e55d8aed0696c87f75d"},"headline":"Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3","datePublished":"2023-07-27T14:02:00+00:00","dateModified":"2023-08-01T09:10:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/"},"wordCount":15,"publisher":{"@id":"https:\/\/pruefer.eu\/zh-hans\/#organization"},"image":{"@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/#primaryimage"},"thumbnailUrl":"https:\/\/pruefer.eu\/wp-content\/uploads\/2023\/07\/UPC_AO_EN.png","articleSection":["UPC-Updates"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/","url":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/","name":"Chances and Risks of the New European Unitary Patentand New Unified Patent Court - Part 3 - Pr\u00fcfer & Partner","isPartOf":{"@id":"https:\/\/pruefer.eu\/zh-hans\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/#primaryimage"},"image":{"@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/#primaryimage"},"thumbnailUrl":"https:\/\/pruefer.eu\/wp-content\/uploads\/2023\/07\/UPC_AO_EN.png","datePublished":"2023-07-27T14:02:00+00:00","dateModified":"2023-08-01T09:10:16+00:00","breadcrumb":{"@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/#primaryimage","url":"https:\/\/pruefer.eu\/wp-content\/uploads\/2023\/07\/UPC_AO_EN.png","contentUrl":"https:\/\/pruefer.eu\/wp-content\/uploads\/2023\/07\/UPC_AO_EN.png","width":1316,"height":1244},{"@type":"BreadcrumbList","@id":"https:\/\/pruefer.eu\/zh-hans\/2023\/07\/27\/chances-and-risks-of-the-new-european-unitary-patentand-new-unified-patent-court-part-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pruefer.eu\/zh-hans\/"},{"@type":"ListItem","position":2,"name":"Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3"}]},{"@type":"WebSite","@id":"https:\/\/pruefer.eu\/zh-hans\/#website","url":"https:\/\/pruefer.eu\/zh-hans\/","name":"Pr\u00fcfer & Partner","description":"Patentanwaltskanzlei f\u00fcr Pharma, Biotech, Life Sciences und Physik \u2013 M\u00fcnchen","publisher":{"@id":"https:\/\/pruefer.eu\/zh-hans\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pruefer.eu\/zh-hans\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/pruefer.eu\/zh-hans\/#organization","name":"Pr\u00fcfer & Partner","url":"https:\/\/pruefer.eu\/zh-hans\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/pruefer.eu\/zh-hans\/#\/schema\/logo\/image\/","url":"https:\/\/pruefer.eu\/wp-content\/uploads\/2022\/07\/logo.svg","contentUrl":"https:\/\/pruefer.eu\/wp-content\/uploads\/2022\/07\/logo.svg","width":"1024","height":"1024","caption":"Pr\u00fcfer & Partner"},"image":{"@id":"https:\/\/pruefer.eu\/zh-hans\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pruefer.eu\/zh-hans\/#\/schema\/person\/51bff1b60ea94e55d8aed0696c87f75d","name":"Schantl","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/a9b62b3711d001a8ab054887513338b1773069eca4c7d3becec0f7ab592eb411?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a9b62b3711d001a8ab054887513338b1773069eca4c7d3becec0f7ab592eb411?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a9b62b3711d001a8ab054887513338b1773069eca4c7d3becec0f7ab592eb411?s=96&d=mm&r=g","caption":"Schantl"}}]}},"_links":{"self":[{"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/posts\/12006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/comments?post=12006"}],"version-history":[{"count":7,"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/posts\/12006\/revisions"}],"predecessor-version":[{"id":12026,"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/posts\/12006\/revisions\/12026"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/media\/11832"}],"wp:attachment":[{"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/media?parent=12006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/categories?post=12006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pruefer.eu\/zh-hans\/wp-json\/wp\/v2\/tags?post=12006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}